The role of prejudice and prior contact in support for evidence-based interventions to reduce drug-related deaths: A mixed methods study
- Nicole M Miller, Claire Campbell and Gillian W Shorter
- May 4
- 2 min read
Authors
Nicole M Miller, Claire Campbell and Gillian W Shorter
Published
May 5, 2025
Abstract
Background
Stigmatised attitudes, opinions on opioid use, and prior contact with People Who Use Drugs (PWUD) contribute to what policies are publicly supported and implemented to reduce drug-related deaths. This study examined how these variables relate to policy support for the implementation of supervised injection sites, laws protecting bystanders at the scene of an overdose, and over-the-counter naloxone.
Methods
An opportunity sample of 472 adults across the Island of Ireland completed an online survey. Hierarchical linear regression was performed to examine associations between respondent attitudes and policy support. Mediation analysis explored how stigma mediated the relationship between prior contact and policy support. Open-ended questions explored attitudes further and were analysed using codebook thematic analysis.
Results
The final model accounted for 29% of the variance in policy support. Unsympathetic attitudes towards people who use opioids predicted less policy support (β = −0.18) and agreement that PWUD were not criminals predicted more policy support (β = 0.14). Medium or high levels of familiarity with PWUD (compared to low) reduced social stigma, avoidance, and disgust which increased levels of policy support. Medium familiarity (compared to low) showed a small indirect effect via sympathetic attitudes and condemnation. Meta-inferences from the qualitative analysis evidenced mechanisms of stigma and prior contact.
Conclusion
Stigma reduction programmes should consider the role of prejudice and target negative emotional reactions such as lack of sympathy towards PWUD. Stigma reduction programmes should be informed by the lived or living experience of PWUD, families and carers, to help increase social acceptance, understanding, and policy support.
To access the full publication from the Drug Science Policy and Law journal, please see below:
